TIAA CREF INVESTMENT MANAGEMENT LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q1 2019$1,145,000
-41.4%
18,372
-43.0%
0.00%
-50.0%
Q4 2018$1,954,000
-52.9%
32,242
-54.5%
0.00%
+100.0%
Q3 2018$4,148,000
+157.3%
70,924
+97.4%
0.00%0.0%
Q2 2018$1,612,000
+12.1%
35,925
+10.8%
0.00%0.0%
Q1 2018$1,438,000
+30.7%
32,423
+27.7%
0.00%0.0%
Q4 2017$1,100,000
-15.0%
25,383
-8.8%
0.00%0.0%
Q3 2017$1,294,000
-16.2%
27,825
-10.8%
0.00%0.0%
Q2 2017$1,544,000
-17.3%
31,190
-8.5%
0.00%0.0%
Q1 2017$1,868,000
-3.3%
34,094
-1.7%
0.00%0.0%
Q4 2016$1,931,000
+21.6%
34,666
-0.3%
0.00%0.0%
Q3 2016$1,588,000
-11.5%
34,765
-22.7%
0.00%0.0%
Q2 2016$1,795,000
+31.6%
44,949
+14.7%
0.00%0.0%
Q1 2016$1,364,000
-31.9%
39,177
-16.0%
0.00%0.0%
Q4 2015$2,003,000
-1.3%
46,6170.0%0.00%
-50.0%
Q3 2015$2,030,000
+40.3%
46,617
+66.2%
0.00%
+100.0%
Q2 2015$1,447,000
+45.1%
28,048
+10.2%
0.00%0.0%
Q1 2015$997,000
-11.4%
25,462
-12.6%
0.00%0.0%
Q4 2014$1,125,000
+34.2%
29,123
+22.6%
0.00%0.0%
Q3 2014$838,000
+63.4%
23,747
+24.7%
0.00%
Q2 2014$513,00019,0450.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2016
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders